An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk.
Selective estrogen receptor modulators (SERMs) are effective therapeutics that preserve favorable actions of estrogens on bone and act as antiestrogens in breast tissue, decreasing the risk of vertebral fractures and breast cancer, but their potential in neuroprotective and procognitive therapy is l...
Guardado en:
Autores principales: | Lawren VandeVrede, Ramy Abdelhamid, Zhihui Qin, Jaewoo Choi, Sujeewa Piyankarage, Jia Luo, John Larson, Brian M Bennett, Gregory R J Thatcher |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/92d1a967b51f498891eff088417ce0b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neurogenic-dependent changes in hippocampal circuitry underlie the procognitive effect of exercise in aging mice
por: Xiaoqing Alice Zhou, et al.
Publicado: (2021) -
Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen
por: Ava Soltani Hekmat, et al.
Publicado: (2021) -
Estrogen receptor-mediated neuroprotection: The role of the Alzheimer’s disease-related gene seladin-1
por: Alessandro Peri, et al.
Publicado: (2008) -
Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
por: Robert W. Maitta, et al.
Publicado: (2021) -
THROMBOTIC THROMBOCYTOPENIC PURPURA: OUR CLINICAL EXPERIENCE
por: Zahid Farooq Baig, et al.
Publicado: (2018)